NASDAQ$MASI
Masimo Corp. · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Masimo's Q3 2022 financial results were reported, with revenue and earnings exceeding expectations.
Masimo reported strong Q3 2022 results, with consolidated revenue of $549.3 million, a 78.7% increase compared to Q3 2021. Healthcare revenue grew by 6.4% to $327.2 million, and non-healthcare revenue was $222.1 million. GAAP net income was $37.9 million, or $0.70 per diluted share, while non-GAAP net income was $53.9 million, or $1.00 per diluted share.
- Consolidated revenue reached $549 million.
- Healthcare revenue was $327 million, demonstrating 6% reported growth and 10% constant currency growth.
- Non-healthcare revenue amounted to $222 million.
- GAAP net income was $37.9 million, or $0.70 per diluted share; non-GAAP net income was $53.9 million, or $1.00 per diluted share.
Headline financials
Revenue & EPS history
Masimo · Revenue · Quarterly
$549M
Forward guidance
The Company provided the following estimates for its fourth quarter and full year 2022 guidance:
Tailwinds
- Consolidated revenue is expected to be between $581 million and $611 million for Q4 2022.
- Healthcare revenue is projected to be between $337 million and $352 million for Q4 2022.
- Non-healthcare revenue is anticipated to be between $245 million and $260 million for Q4 2022.
- Consolidated earnings per diluted share are estimated to be between $0.80 and $0.92 (GAAP) or $1.11 and $1.22 (Non-GAAP) for Q4 2022.
- Full year 2022 revenue guidance includes year-over-year foreign currency headwinds of $35.0 million for healthcare segment.
Headwinds
- Fourth quarter 2022 and full year 2022 revenue guidance includes year-over-year foreign currency headwinds of $13.6 million and $35.0 million, respectively for healthcare segment.
- Global economic and marketplace uncertainties related to the impact of the COVID-19 pandemic
- Dependence on Masimo SET® and Masimo rainbow SET™ products and technologies for substantially all of revenue
- Any failure in protecting intellectual property exposure to competitors’ assertions of intellectual property claims
- The highly competitive nature of the markets in which products and technologies are sold
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2022
-0.6%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+1.6%
Avg return
30 days after
54%
35 / 65 earnings
Positive
+17.2%
Q2 2024
Best reaction
-35.8%
Q4 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +0.1% | +0.4% | |
| Q4 2025 | +0.1% | +7.4% | +0.6% | |
| Q3 2025 | -4.8% | -3.0% | -4.9% | |
| Q1 2025 | -6.5% | +1.3% | +6.5% | |
| Q4 2024 | +12.3% | +12.4% | -3.5% | |
| Q3 2024 | +13.7% | +10.2% | +14.9% | |
| Q2 2024 | +17.2% | +21.1% | +9.0% | |
| Q1 2024 | -13.0% | -11.8% | -9.6% | |
| Q4 2023 | -1.5% | -3.2% | +12.4% | |
| Q3 2023 | +2.5% | +6.6% | +30.5% | |
| Q2 2023 | -4.1% | -7.6% | -11.8% | |
| Q1 2023 | -7.0% | -8.0% | -16.1% | |
| Q4 2022 | +4.1% | +7.9% | +5.6% | |
| Q3 2022 | -12.1% | +3.1% | +10.1% | |
| Q2 2022 | +2.1% | -0.2% | -0.4% | |
| Q1 2022 | +7.5% | +8.5% | +19.8% | |
| Q4 2021 | -35.8% | -31.3% | -29.9% | |
| Q3 2021 | +1.4% | -0.7% | +0.1% | |
| Q2 2021 | -0.6% | +2.3% | +3.8% | |
| Q1 2021 | -6.9% | -5.5% | -12.4% | |
| Q4 2020 | +0.5% | +0.3% | -9.6% | |
| Q3 2020 | -5.1% | -9.0% | -0.3% | |
| Q2 2020 | -7.2% | -6.6% | -6.7% | |
| Q1 2020 | -0.6% | +1.7% | +9.3% | |
| Q4 2019 | +0.2% | -4.5% | -14.5% | |
| Q3 2019 | -1.5% | -2.2% | +4.7% | |
| Q2 2019 | -2.8% | -7.8% | -3.2% | |
| Q1 2019 | -1.5% | +1.1% | -2.9% | |
| Q4 2018 | +1.3% | +3.9% | +5.5% | |
| Q3 2018 | -2.2% | -3.3% | -4.5% | |
| Q2 2018 | +8.9% | +9.1% | +18.6% | |
| Q1 2018 | +4.3% | +7.6% | +10.2% | |
| Q4 2017 | +2.2% | -1.4% | +2.7% | |
| Q3 2017 | +1.3% | -1.0% | +2.3% | |
| Q2 2017 | -10.3% | -10.8% | -11.5% | |
| Q1 2017 | -14.2% | -17.0% | -12.5% | |
| Q4 2016 | +5.7% | +11.1% | +21.9% | |
| Q3 2016 | +5.5% | +10.7% | +12.3% | |
| Q2 2016 | +9.3% | +6.1% | +14.0% | |
| Q1 2016 | +7.7% | — | — | |
| Q4 2015 | +5.7% | — | — | |
| Q3 2015 | +4.0% | — | — | |
| Q2 2015 | +6.2% | — | — | |
| Q1 2015 | +1.0% | — | — | |
| Q4 2014 | +8.0% | — | — | |
| Q3 2014 | +7.0% | — | — | |
| Q2 2014 | -11.2% | — | — | |
| Q1 2014 | -9.1% | — | — | |
| Q4 2013 | -4.2% | — | — | |
| Q3 2013 | -9.2% | — | — | |
| Q2 2013 | +5.5% | — | — | |
| Q1 2013 | +7.5% | — | — | |
| Q4 2012 | -0.3% | — | — | |
| Q3 2012 | -1.1% | — | — | |
| Q2 2012 | -6.2% | — | — | |
| Q1 2012 | -6.6% | — | — | |
| Q4 2009 | -3.8% | — | — | |
| Q4 2011 | -3.8% | — | — | |
| Q3 2011 | +1.1% | — | — | |
| Q2 2011 | -8.4% | — | — | |
| Q1 2011 | +4.0% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2010 | +1.1% | — | — | |
| Q4 2010 | +1.1% | — | — | |
| Q1 2010 | +2.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro